CPGR enters final phase of MADCaP prostate cancer project


April 15, 2019 —Cape Town, South Africa — The Centre for Proteomic & Genomic Research (CPGR) announced that it has entered into a critical last phase of the MADCaP project, a pan-African genome-wide association study aimed at identifying genetic risk factors that underpin prostate cancer development in men of African descent.


Full coverage here:

https://www.cpgr.org.za/cpgr-enters-into-final-phase-of-madcap-prostate-cancer-project/

4 views0 comments

Recent Posts

See All

MADCaP Network
Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215

Supported by Dana-Farber Cancer Institute

MADCaP is grant-funded by the National Cancer Institute

© Copyright 2016-2020 

Dana-Farber Cancer Institute.

Use of MADCaP is subject to our terms of use and our privacy policy.

NCI_Stacked_COLOR.png
img-logo-2x-new.png